7634
HOSHIIRYO-SANKI CO.,LTD.
星医療酸器
- Industry
- Wholesale Trade
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Mar 2021
11,809,283
Mar 2022
12,771,787
Mar 2023
13,779,777
Mar 2024
14,778,211
Mar 2025
15,102,329
Operating profit(thousand JPY)
Mar 2021
1,440,993
Mar 2022
1,595,208
Mar 2023
1,777,855
Mar 2024
1,961,803
Mar 2025
1,982,289
Operating profit margin(%)
Mar 2021
12.2
Mar 2022
12.49
Mar 2023
12.9
Mar 2024
13.27
Mar 2025
13.13
Profit before tax(thousand JPY)
Mar 2021
1,456,832
Mar 2022
1,622,824
Mar 2023
1,791,496
Mar 2024
2,045,978
Mar 2025
2,063,694
Profit(thousand JPY)
Mar 2021
993,978
Mar 2022
1,107,203
Mar 2023
1,253,684
Mar 2024
1,404,312
Mar 2025
1,463,492
Total assets(thousand JPY)
Mar 2021
18,988,261
Mar 2022
20,252,282
Mar 2023
21,247,181
Mar 2024
23,037,216
Mar 2025
24,590,021
Cash and cash equivalents(thousand JPY)
Mar 2021
8,372,714
Mar 2022
8,720,258
Mar 2023
8,991,480
Mar 2024
9,755,745
Mar 2025
5,925,818
Cash flows from operating activities(thousand JPY)
Mar 2021
2,479,641
Mar 2022
1,974,706
Mar 2023
2,288,045
Mar 2024
2,395,450
Mar 2025
2,189,777
Cash flows from investing activities(thousand JPY)
Mar 2021
-64,142
Mar 2022
-690,264
Mar 2023
-1,059,128
Mar 2024
-744,854
Mar 2025
-5,284,726
Cash flows from financing activities(thousand JPY)
Mar 2021
-1,440,618
Mar 2022
-936,899
Mar 2023
-957,694
Mar 2024
-902,905
Mar 2025
-739,640
Return on equity(%)
Mar 2021
7.6
Mar 2022
8
Mar 2023
8.5
Mar 2024
8.7
Mar 2025
8.2
Equity ratio(%)
Mar 2021
69.8
Mar 2022
70.6
Mar 2023
72.3
Mar 2024
74.2
Mar 2025
74.9
Earnings per share(JPY per share)
Mar 2021
313.14
Mar 2022
358.33
Mar 2023
402.98
Mar 2024
450.7
Mar 2025
469.18
Net assets per share(JPY per share)
Mar 2021
4,289.53
Mar 2022
4,594.54
Mar 2023
4,931.68
Mar 2024
5,481.61
Mar 2025
5,900.59
Dividend per share(JPY per share)
Mar 2021
50
Mar 2022
55
Mar 2023
60
Mar 2024
70
Mar 2025
70
Payout ratio(%)
Mar 2021
15.97
Mar 2022
15.35
Mar 2023
14.89
Mar 2024
15.53
Mar 2025
14.92
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.